Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xeris Biopharma Holdings (XERS) Asset Utilization Ratio (2021 - 2025)

Historic Asset Utilization Ratio for Xeris Biopharma Holdings (XERS) over the last 5 years, with Q3 2025 value amounting to 0.76.

  • Xeris Biopharma Holdings' Asset Utilization Ratio rose 3155.81% to 0.76 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.76, marking a year-over-year increase of 3155.81%. This contributed to the annual value of 0.63 for FY2024, which is 2800.62% up from last year.
  • Xeris Biopharma Holdings' Asset Utilization Ratio amounted to 0.76 in Q3 2025, which was up 3155.81% from 0.76 recorded in Q2 2025.
  • Xeris Biopharma Holdings' 5-year Asset Utilization Ratio high stood at 0.76 for Q2 2025, and its period low was 0.2 during Q1 2022.
  • In the last 5 years, Xeris Biopharma Holdings' Asset Utilization Ratio had a median value of 0.48 in 2023 and averaged 0.47.
  • In the last 5 years, Xeris Biopharma Holdings' Asset Utilization Ratio skyrocketed by 8436.86% in 2023 and then surged by 2342.47% in 2024.
  • Xeris Biopharma Holdings' Asset Utilization Ratio (Quarter) stood at 0.23 in 2021, then skyrocketed by 49.56% to 0.34 in 2022, then soared by 48.03% to 0.5 in 2023, then grew by 25.08% to 0.63 in 2024, then increased by 19.77% to 0.76 in 2025.
  • Its Asset Utilization Ratio was 0.76 in Q3 2025, compared to 0.76 in Q2 2025 and 0.7 in Q1 2025.